Exact Mass: 388.2460906
Exact Mass Matches: 388.2460906
Found 82 metabolites which its exact mass value is equals to given mass value 388.2460906
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
5,6-Dihydroxyprostaglandin F1a
Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways. [HMDB] Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways.
Palmitoleoyl 3-carbacyclic Phosphatidic Acid
C20H37O5P (388.23784820000003)
Gly Gly Lys Lys
C16H32N6O5 (388.24340620000004)
Gly Lys Gly Lys
C16H32N6O5 (388.24340620000004)
Gly Lys Lys Gly
C16H32N6O5 (388.24340620000004)
Lys Gly Gly Lys
C16H32N6O5 (388.24340620000004)
Lys Gly Lys Gly
C16H32N6O5 (388.24340620000004)
Lys Lys Gly Gly
C16H32N6O5 (388.24340620000004)
3-[4-(N-Boc)piperazin-1-yl]phenylboronic acid pinacol ester
C21H33BN2O4 (388.25332480000003)
1,2-bis(ethenyl)benzene,buta-1,3-diene,methyl 2-methylprop-2-enoate,styrene
Galeterone
C26H32N2O (388.25145019999997)
D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor
8,8-bis(1H-indol-3-yl)-2,6-dimethyl-2-octanol
C26H32N2O (388.25145019999997)
4-(4-Boc-piperazino)phenylboronic Acid Pinacol Ester
C21H33BN2O4 (388.25332480000003)
2-[4-(N-Boc)piperazin-1-yl]phenylboronic acid pinacol ester
C21H33BN2O4 (388.25332480000003)
2,8-Diazaspiro[4.5]decane-2,8-dicarboxylic acid, 2-(1,1-dimethylethyl) 8-(phenylmethyl) ester
(2S)-6-amino-2-[[(2S)-4-amino-2-[[(2S)-2,6-diaminohexanoyl]amino]-4-oxobutanoyl]amino]hexanoic acid
C16H32N6O5 (388.24340620000004)
N-oleoyltaurine(1-)
C20H38NO4S- (388.25214080000006)
A fatty acid-taurine conjugate obtained by deprotonation of the sulfonate group of N-oleoyltaurine; major species at pH 7.3.
(13R)-13-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxotetradecanoic acid
14-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxotetradecanoic acid
2-[(1S,3S,4aS,9aR)-6-(dimethylamino)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-cyclohexylacetamide
(1R,9S,10S,11S)-12-(cyclopropylmethyl)-N-[3-(dimethylamino)propyl]-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C21H32N4O3 (388.24742819999994)
N-[[(2R,3S,4S)-1-acetyl-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidin-2-yl]methyl]-2-methoxy-N-propan-2-ylacetamide
N-[[(2R,3S,4R)-1-acetyl-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidin-2-yl]methyl]-2-methoxy-N-propan-2-ylacetamide
N-[[(2S,3R,4S)-1-acetyl-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidin-2-yl]methyl]-2-methoxy-N-propan-2-ylacetamide
N-[[(2S,3R,4R)-1-acetyl-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidin-2-yl]methyl]-2-methoxy-N-propan-2-ylacetamide
(1S,9R,10R,11R)-12-(cyclopropylmethyl)-N-[3-(dimethylamino)propyl]-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C21H32N4O3 (388.24742819999994)
(E,E)-(1R,2S,5R)-8-Phenylmenthyl 5-phenyl-2,4-pentadienoate
(1r,4s,7e,9s,10s,13s)-5,5,9,13-tetramethyl-7-(phenylmethylidene)tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-ene-6,12-dione
(1s,2s)-2-hydroxy-1-tetradecylpropane-1,2,3-tricarboxylic acid
(2e)-3-(3,4-dimethoxyphenyl)-n-{4-[n'-(3-methylbut-2-en-1-yl)carbamimidamido]butyl}prop-2-enimidic acid
C21H32N4O3 (388.24742819999994)